The problem nobody has solved
CYP2C19*2 loss-of-function affects 23% of South Asians vs 15% globally. Standard clopidogrel dosing is wrong for 300M Indians. No global KG knows this.
17,967 Ayurvedic phytochemicals catalogued in IMPPAT 2.0. Zero mechanistic evidence in any global knowledge graph. CDSCO requires computational validation — no tool provides it. We have curated 100 high-export compounds; full ingestion via ACTREC academic agreement in progress.
India has 3,000 pathologists for 1.4B people. Retinal fundus cameras are everywhere. No tool connects the image to Indian genetic context and treatment pathways.
Platform modules
Find FDA-approved drugs with mechanistic connections to any disease — through protein targets, shared pathways, and Indian genetic context. Multi-hop paths, not guesses.
Generate computational mechanism certificates for IMPPAT phytochemicals. Protein binding → pathway → disease evidence for CDSCO and EU regulatory submissions.
CYP2C19*2 is 23% in South Asia vs 15% globally. Standard guidelines are wrong for 300M Indians. Explore how Indian-enriched variants change drug dosing and selection.
Upload a retinal fundus, blood smear, or biopsy. AI extracts biomarkers, maps them to the knowledge graph, and returns treatment paths with active Indian trial data.
Under the hood
Retinal fundus → DR grade + VEGF pathway drugs + CYP2C19 warning. Blood smear → P. falciparum vs vivax + G6PD alert + artemisinin protocol. Biopsy → HER2 status + active Indian trials. All in under 60 seconds.
Try Vision Module →Built on open science